*Naoki Yamamoto^1,4, Hisayuki Osanai¹, Mark Henkemeyer^2,3, Sachie K Ogawa^1,3, Takashi Kitamura^1,2,3 (1. Dept of Psychiatry, Univ of Texas Southwestern Medical Center, Dallas, USA, 2. Dept of Neuroscience, Univ of Texas Southwestern Medical Center, Dallas, USA, 3. Peter O'Donnell Brain Institute, Univ of Texas Southwestern Medical Center, Dallas, USA, 4. Dept of Biology, Faculty of Science, Kyushu University, Fukuoka, Japan)

*Tianying Wang¹, Yasuomi Ouchi¹ (1. Hamamatsu University School of Medicine)

*Rieko Tanaka¹, Tatsuya Sameshima¹, Rie Yamoto¹, Manabu Seo², Toshihiko Hosoya¹ (1. Ricoh Company, Ltd., 2. Elixirgen Scientific, Inc.)

*Ting Wang¹, Akira Sobue^1,2, Seiji Watanabe¹, Okiru Komine¹, Takashi Saito³, Takaomi Saido⁴, Koji Yamanaka¹ (1. RIEM, Univ of Nagoya, Nagoya, Japan, 2. RIEM, Univ of Nagoya, Nagoya, Japan , 3. Institute Brain center Grad Sch Med , Univ of Nagoya City , Nagoya , 4. RIKEN Center for Brain Science , Tokyo , Japan )

*Sho Takatori¹, Hayato Etani¹, Wenbo Wang¹, Jumpei Omi¹, Aika Akahori¹, Hirotaka Watanabe², Hideyuki Okano², Takashi Saito³, Takaomi C Saido⁴, Toshiyuki Takai⁵, Tomohiko Ohwada¹, Junken Aoki¹, Taisuke Tomita¹ (1. Grad Sch Pharm Sci, Univ Tokyo, Tokyo, Japan, 2. Keio Univ Sch Med, Tokyo, Japan, 3. Grad Sch Med Sci, Nagoya City Univ, Nagoya, Aichi, Japan, 4. RIKEN CBS, Wako, Saitama, Japan, 5. Inst of Dev Aging and Cancer, Tohoku Univ, Sendai, Japan)

*Hiroshi Kokubu¹, Satoru Hayashi¹, Komei Fukushima¹, Hideyuki Okano^1,2 (1. K Pharma Inc., 2. Department of Physiology, Keio University School of Medicine)

*Alex Gola^1,2, Euncheng Suh², Kyungeun Lee² (1. Life Sciences, McMaster University, Ontario, Canada, 2. Department of Pharmacology, College of Medicine, Ewha Womans University, Seoul, Republic of Korea)